GDF15的对抗作用限制了严重的心力衰竭,并防止了心脏缓冲症
Minoru Takaoka1, John A Tadross2,3, Ali B A K Al-Hadithi1
1Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge CB2 0QQ, UK.
Cardiovascular research
|September 23, 2024
概括
心脏缓解症是由一个依赖GDF15的途径恶化. 阻断心力衰竭中的GDF15活动可以防止体重减轻和改善心脏功能,提供一种新的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 生理学 生理学 生理学
背景情况:
- 心力衰竭和相关的缓冲症仍然是重大的临床挑战.
- 综合应激反应 (ISR) 在细胞应激和适应中发挥作用.
- PPP1R15A是一种ISR诱导的eIF2α酸酶,与应激反应途径有关.
研究的目的:
- 为了研究PPP1R15A缺乏在心力衰竭的新型小鼠模型中的作用.
- 在这个模型中识别导致心脏缓冲症的因素.
- 探索针对心力衰竭诱导的缓解症中的特定途径的治疗潜力.
主要方法:
- 通过辐射和骨髓复合,产生缺乏功能性PPP1R15A的小鼠.
- 评估心脏功能和体重变化.
- 测量心脏中的GDF15表达和循环中的GDF15水平.
- 评估GDF15活动阻断对缓冲症和心力衰竭进展的影响.
- 在人类心力衰竭患者中分析GDF15与瘦身量和蛋白质摄入量相关性的分析.
主要成果:
- 缺乏PPP1R15A的小鼠在照射后出现了扩张性心肌病症和严重的体重减轻.
- 野生型小鼠没有显示任何不良影响.
- 在受影响的小鼠中观察到心脏中的Gdf15表达增加和循环中的GDF15水平升高.
- 阻断GDF15活动改善了缓冲症,并减缓了心力衰竭的进展.
- 人类心力衰竭患者的GDF15水平与瘦身量和蛋白质摄入量相关.
结论:
- 心脏压力激活了一条依赖GDF15的途径,导致体重减轻和心脏功能障碍.
- 准GDF15代表了一种潜在的治疗策略,可以缓解心脏缓解症.
- 对GDF15的干预可能会改善严重心力衰竭患者的临床结果.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
01:26Heart Failure Drugs: Inotropic Agents
539
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
539
01:22Heart Failure Drugs: Diuretics
349
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
349
01:22Heart Failure Drugs: β-Blockers
320
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
320
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K